Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy? — Positive

OGN   Zacks Investment Research — July 29, 2025

Organon (OGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Organon (OGN) Expected to Beat Earnings Estimates: Should You Buy?

Earnings Preview: Marathon Petroleum (MPC) Q2 Earnings Expected to Decline — Negative

MPC   Zacks Investment Research — July 29, 2025

Marathon Petroleum (MPC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: Marathon Petroleum (MPC) Q2 Earnings Expected to Decline

PSEG (PEG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Neutral

PEG   Zacks Investment Research — July 29, 2025

PSEG (PEG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news PSEG (PEG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy? — Positive

PFE   Zacks Investment Research — July 29, 2025

Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Pfizer (PFE) Expected to Beat Earnings Estimates: Should You Buy?

ONE Gas (OGS) Earnings Expected to Grow: Should You Buy? — Positive

OGS   Zacks Investment Research — July 29, 2025

ONE Gas (OGS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news ONE Gas (OGS) Earnings Expected to Grow: Should You Buy?

Analysts Estimate Sealed Air (SEE) to Report a Decline in Earnings: What to Look Out for — Negative

SEE   Zacks Investment Research — July 29, 2025

Sealed Air (SEE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Analysts Estimate Sealed Air (SEE) to Report a Decline in Earnings: What to Look Out for

Southwest Gas (SWX) Earnings Expected to Grow: What to Know Ahead of Q2 Release — Positive

SWX   Zacks Investment Research — July 29, 2025

Southwest Gas (SWX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Southwest Gas (SWX) Earnings Expected to Grow: What to Know Ahead of Q2 Release

Earnings Preview: Molson Coors Brewing (TAP) Q2 Earnings Expected to Decline — Negative

TAP   Zacks Investment Research — July 29, 2025

Molson Coors (TAP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: Molson Coors Brewing (TAP) Q2 Earnings Expected to Decline

Earnings Preview: Sally Beauty (SBH) Q3 Earnings Expected to Decline — Negative

SBH   Zacks Investment Research — July 29, 2025

Sally Beauty (SBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: Sally Beauty (SBH) Q3 Earnings Expected to Decline

Earnings Preview: TXO Partners LP (TXO) Q2 Earnings Expected to Decline — Negative

TXO   Zacks Investment Research — July 29, 2025

TXO Partners LP (TXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: TXO Partners LP (TXO) Q2 Earnings Expected to Decline

Earnings Preview: Westlake Chemical (WLK) Q2 Earnings Expected to Decline — Negative

WLK   Zacks Investment Research — July 29, 2025

Westlake (WLK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Earnings Preview: Westlake Chemical (WLK) Q2 Earnings Expected to Decline

Yum Brands (YUM) Earnings Expected to Grow: Should You Buy? — Positive

YUM   Zacks Investment Research — July 29, 2025

Yum (YUM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Yum Brands (YUM) Earnings Expected to Grow: Should You Buy?

TransDigm Group (TDG) Reports Next Week: Wall Street Expects Earnings Growth — Positive

TDG   Zacks Investment Research — July 29, 2025

TransDigm (TDG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news TransDigm Group (TDG) Reports Next Week: Wall Street Expects Earnings Growth

Doubling down on hospitality: Starbucks COO on ‘Green Apron Service' — Positive

SBUX   CNBC Television — July 29, 2025

CNBC's Kate Rogers sits down with Starbucks COO Mike Grams to discuss the rollout of the company's Green Apron Service initiative, aimed at creating warmer interactions between customers and baristas while maintaining turnaround times of four minutes or fewer for digital and in-store orders.

image for news Doubling down on hospitality: Starbucks COO on ‘Green Apron Service'

Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Analysts Estimate Acadia Healthcare (ACHC) to Report a Decline in Earnings: What to Look Out for

AC Immune (ACIU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release — Positive

ACIU   Zacks Investment Research — July 29, 2025

AC Immune (ACIU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news AC Immune (ACIU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Advanced Energy (AEIS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

image for news Advanced Energy Industries (AEIS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In RxSight To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in RxSight between November 7, 2024 and July 8, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK , July 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against RxSight, Inc. ("RxSight" or …

image for news DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight

Brown & Brown, Inc. (BRO) Q2 2025 Earnings Call Transcript — Neutral

BRO   Seeking Alpha — July 29, 2025

Brown & Brown, Inc. (NYSE:BRO ) Q2 2025 Earnings Conference Call July 29, 2025 8:00 AM ET Company Participants J. Powell Brown - CEO, President & Director R.

image for news Brown & Brown, Inc. (BRO) Q2 2025 Earnings Call Transcript

If You Suffered Losses Exceeding $50,000 in Capricor between October 9, 2024 and July 10, 2025 Securities Litigation Partner James (Josh) Wilson Encourages you to contact him directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here to find out if you qualify for the class action] NEW YORK , July 29, 2025 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Capricor Therapeutics, Inc. ("Capricor" or the "Company") (NASDAQ: CAPR) and reminds investors of the September 15, 2025 deadline to seek the role of lead plaintiff in a federal …

image for news Shareholders that lost money on Capricor Therapeutics should contact Faruqi & Faruqi about pending Class Action - CAPR